IAGG workshop: health promotion program on prevention of late onset dementia
- PMID: 21808935
- DOI: 10.1007/s12603-011-0142-1
IAGG workshop: health promotion program on prevention of late onset dementia
Abstract
IAGG, WHO, and SFGG organized a international workshop on Health promotion programs on prevention of late on-set dementia. Thirty world specialists coming from Europe, North America, Asia, South America, Africa and Australia, shared their experience on methods and results of large epidemiological interventions to reduce incidents of dementia or delay its on-set. Chaired by Laura FRATIGLIONI, an expert in Epidemiological studies on dementia issues, the workshop gave opportunity for discussions and controversies about the state-of-the-art. Based on different national and international trials (ADAPT, MAPT, FINGER, GUDIAGE, GEM etc) the questions remained opened for different aspects of methodology, the choice of domain or multi domain intervention, the choice and the definition of the target populations, the best age of candidates, the issues related to the discrepancy between late effects, and interventions' duration. We are please to publish in the Journal, the presentations presented to this workshop. These publications will complete previously task force published in the journal in the last two years on methodological issues for Alzheimer's trials including end point, biomarkers, and the experience of past therapeutic trials.
Similar articles
-
Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.J Prev Alzheimers Dis. 2020;7(1):29-36. doi: 10.14283/jpad.2019.41. J Prev Alzheimers Dis. 2020. PMID: 32010923 Free PMC article.
-
Design and sample size considerations for Alzheimer's disease prevention trials using multistate models.Clin Trials. 2019 Apr;16(2):111-119. doi: 10.1177/1740774518816323. Clin Trials. 2019. PMID: 30922116 Free PMC article.
-
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.Alzheimers Res Ther. 2018 Nov 24;10(1):116. doi: 10.1186/s13195-018-0443-2. Alzheimers Res Ther. 2018. PMID: 30474567 Free PMC article.
-
Prevention of Alzheimer's disease: moving backward through the lifespan.J Alzheimers Dis. 2013;33 Suppl 1:S465-9. doi: 10.3233/JAD-2012-129021. J Alzheimers Dis. 2013. PMID: 22751171 Review.
-
Future directions in Alzheimer's disease from risk factors to prevention.Biochem Pharmacol. 2014 Apr 15;88(4):661-70. doi: 10.1016/j.bcp.2014.01.003. Epub 2014 Jan 10. Biochem Pharmacol. 2014. PMID: 24418410 Review.
Cited by
-
Nonpharmacologic treatment and prevention strategies for dementia.Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):372-81. doi: 10.1212/01.CON.0000429178.14354.67. Continuum (Minneap Minn). 2013. PMID: 23558483 Free PMC article. Review.
-
Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).J Nutr Health Aging. 2012 Apr;16(4):355-9. doi: 10.1007/s12603-012-0046-8. J Nutr Health Aging. 2012. PMID: 22499458
-
First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.J Transl Med. 2016 Feb 13;14:50. doi: 10.1186/s12967-016-0806-z. J Transl Med. 2016. PMID: 26873444 Free PMC article.
-
Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.J Neurol Neurophysiol. 2017 Feb;8(1):413. doi: 10.4172/2155-9562.1000413. Epub 2017 Feb 8. J Neurol Neurophysiol. 2017. PMID: 28690913 Free PMC article.
-
Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.J Neurovirol. 2013 Dec;19(6):574-85. doi: 10.1007/s13365-013-0219-1. Epub 2013 Dec 12. J Neurovirol. 2013. PMID: 24338243 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous